en
  • Deutsch - de
  • English - en
  • About
      About us
        Our Measures
          Members
            Cluster Management
               PhD & Postdoc representatives
                Scientific Advisory Board
                   International cooperation partners
                    Timeline
                       Media Kit
                        Contact
                      • News & Events
                          News
                            Events
                              In the News
                                Open Positions
                              • Research
                                  Publications
                                    Our Research Focus
                                      Technology Hubs
                                        Research Spotlight
                                          Data Management & Sharing
                                            Sustainability Initiative
                                               Code of Conduct
                                            • Science & Society
                                                For Schools & Students
                                                  Public Events
                                                    Podcasts
                                                      Videos
                                                    • Support for Diversity & Equity
                                                        Newcomer Center
                                                          Gender Equality Program
                                                            Early Career Investigator Program
                                                          1. Home
                                                          2. News & Events
                                                          3. News
                                                          4. Regional tau aggregation is the most significant predictor of neuroinflammation
                                                          News | 31/07/2023 | Research Spotlight

                                                          Regional tau aggregation is the most significant predictor of neuroinflammation

                                                          Understanding how amyloid and tau contribute to neuroinflammation provides valuable insights into neurodegenerative disease mechanisms. Researchers show that regional tau accumulation is the strongest predictor of neuroinflammation in primary tauopathies and AD. 
                                                           Research spotlight: portrait of  researcher and a quote on the impact of their research

                                                          This is a summary of Finze, A., Biechele, G., Rauchmann, BS. et al. Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies. (2023). https://doi.org/10.1038/s41380-023-02188-8, which appeared in Molecular Psychiatry.


                                                          The challenge

                                                          Tauopathies are a class of neurodegenerative disorders involving abnormal tau protein in the brain. They are divided into primary and secondary tauopathies. Alzheimer’s disease (AD) is a so-called secondary tauopathy because it is characterized by a build-up of a second protein that is considered the primary driver: beta-amyloid. Primary tauopathies include, for example, Pick’s disease or progressive supranuclear palsy (PSP). An accumulation of beta-amyloid plaques, tau protein aggregates, and neurodegeneration characterizes Alzheimer’s and primary tauopathies. These symptoms are categorized in a classification scheme for several biomarkers: the ATN (amyloid, Tau, neurodegeneration) framework.

                                                          But this framework only covers some mechanisms in the disease process, and we, therefore, aimed to expand it. We looked at inflammation specifically because it acts as a mediator in the aggregation and spread of amyloid and tau and disease progression: the ATI(N) framework. The interactions between amyloid, tau, and neuroinflammation have only rarely been investigated in atypical Alzheimer’s disease or primary tauopathies, which is what we, therefore, set out to study. Understanding how amyloid and tau contribute to neuroinflammation provides valuable insights into the disease mechanisms.


                                                          Our approach

                                                          As a biomarker for neuroinflammation, we used PET imaging to determine the activation of microglia – the active immune defense in the central nervous system. We investigated the interplay in different brain regions in a cohort of patients with primary and secondary tauopathies, including typical and atypical AD. We investigated the relationship between regional differences in the accumulation of misfolded proteins (amyloid and tau), blood flow, and volume changes within microglial activation at the individual patient level. Using a regression model, we calculated how much each biomarker contributes to microglial activation in the patient, as well as how individual responses of microglia to beta-amyloid and tau impact cognitive performance and cerebrospinal sTREM2 levels.


                                                          Our findings

                                                          Regional accumulation of tau was the strongest predictor of the activation of microglia in primary tauopathies and AD – we found a stronger association between regional aggregation of tau with microglial activation than for amyloid deposits. This finding aligns with a previous study, which suggests that microglial activation correlates strongly with tau aggregation in established AD and with amyloid deposition in mild cognitive impairment. Our results indicate that targeting microglial activation associated with tau pathology could be beneficial at later disease stages, whereas modifying microglial activation related to amyloid may be only helpful in the early stages of the disease.


                                                          The implications

                                                          Our results show that microglial responses related to tau and amyloid can serve as an assessment of neuroinflammation at the individual patient level. This is even more important in light of the recently revised NIA-AA framework that now also suggests assessment of neuroinflammation in Alzheimer’s disease. Therefore, our findings could have a significant impact on selecting appropriate immunomodulatory strategies by determining the current microglia response level in individual patients.


                                                          Creating SyNergies

                                                          This research was a collaboration of 7 of our Principal and Associate Investigators and colleagues from LMU, TUM, and DZNE. All in vivo imaging data was collected in the SyNergy-driven ActiGliA prospective cohort study since 2016. Future SyNergies will investigate the underlying mechanisms of different microglia response rates in individual patients by microglia phenotyping.

                                                          Prof. Dr. med. Matthias Brendel

                                                          LMU Hospital

                                                          vgbbzlgJcejpiumiävimJ fu:l#vfiuyziuemi
                                                          Website

                                                          Participating Universities
                                                           LMU logo in white
                                                           TUM logo in white
                                                          Partner Institutions
                                                           Logo DZNE in white
                                                          Helmholtz Munich logo in white 
                                                           Logo Max Planck Gesellschaft 

                                                          SyNergy is funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the German Excellence Strategy (EXC 2145 SyNergy – ID 390857198). The Excellence Strategy promotes outstanding research at German universities. 

                                                          Contact

                                                          Munich Cluster for Systems Neurology (SyNergy)

                                                          Feodor-Lynen-Str. 17
                                                          81377 Munich
                                                          +49 (0)89 4400-46497
                                                          yüubgyJbcјuJipxј_vfulySz-mi
                                                          Login for editors
                                                          Imprint | Data-Safety
                                                          en
                                                          • Deutsch - de
                                                          • English - en

                                                          Home

                                                          • About
                                                            • About us
                                                            • Our Measures
                                                            • Members
                                                            • Cluster Management
                                                            •  PhD & Postdoc representatives
                                                            • Scientific Advisory Board
                                                            •  International cooperation partners
                                                            • Timeline
                                                            •  Media Kit
                                                            • Contact
                                                          • News & Events
                                                            • News
                                                            • Events
                                                            • In the News
                                                            • Open Positions
                                                          • Research
                                                            • Publications
                                                            • Our Research Focus
                                                            • Technology Hubs
                                                            • Research Spotlight
                                                            • Data Management & Sharing
                                                            • Sustainability Initiative
                                                            •  Code of Conduct
                                                          • Science & Society
                                                            • For Schools & Students
                                                            • Public Events
                                                            • Podcasts
                                                            • Videos
                                                          • Support for Diversity & Equity
                                                            • Newcomer Center
                                                            • Gender Equality Program
                                                            • Early Career Investigator Program